Balaxi Pharmaceuticals has received approval to invest up to $4 million as equity in its wholly owned subsidiary i.e Balaxi Global FZCO (Formerly known as Balaxi Global DMCC), Dubai. The objective for investment in WOS is to extend support for operational and business expansion requirements. The proposed investment would be completed on or before March 31, 2026.
The Board of Directors of the company, in their meeting held on November 11, 2025, has approved the same.
Balaxi Pharmaceuticals is engaged in the business of international wholesale trading of Pharmaceuticals, Builders Hardware and FMCG products.
| Company Name | CMP |
|---|---|
| Redington | 225.05 |
| Adani Enterprises | 2145.20 |
| Amrapali Industries | 17.95 |
| Rashi Peripheral | 440.00 |
| PDS | 302.40 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: